Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mannosyl-glycoprotein N-acetylglucosaminyltransferases (MGATs) are a family of Golgi-resident enzymes essential for the structural diversification of N-linked glycans on proteins (UniProt: P26391, Q10469). These enzymes, including MGAT1, MGAT2, MGAT3, MGAT4, and MGAT5, catalyze the transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to specific mannose residues on the glycan core, thereby initiating the formation of complex branched structures known as antennae (PMID: 19272177). MGAT1 and MGAT2 are required for the synthesis of all complex N-glycans, while MGAT4 and MGAT5 increase branching complexity, which is frequently upregulated in malignant cells to promote growth factor signaling, cell migration, and metastasis (PMID: 18487371). Conversely, MGAT3 adds a bisecting GlcNAc that typically inhibits further branching and can act as a tumor suppressor (PMID: 24511055). Because aberrant N-glycan branching is a hallmark of cancer progression and metabolic dysfunction, these enzymes are significant therapeutic targets, with research focusing on small-molecule inhibitors to modulate glycan profiles in oncology and inflammatory diseases (PMID: 30242148). However, systemic inhibition of these enzymes poses a high risk of developmental toxicity and symptoms resembling Congenital Disorders of Glycosylation (CDG) (PMID: 22230524).
Inhibition of enzyme activity to prevent the formation of complex or branched N-glycan structures on cell surface receptors and secreted proteins, thereby modulating signaling and cell adhesion (PMID: 18487371).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mannosyl-glycoprotein N-acetylglucosaminyltransferase (MGAT).